About this file

Statement of Work Summary: Biospecimen Collection and Biobanking Services (BCBS)

This is a Statement of Work (SOW) for a Multiple Award, Indefinite Delivery Indefinite Quantity (MA IDIQ) base contract to establish biospecimen collection and biorepository services on behalf of the National Institutes of Health (NIH), specifically the National Cancer Institute (DCTD). The contract supports cancer research through collection, processing, storage, and distribution of high-quality biospecimens (tissues, blood, and other bodily fluids) from consented research participants enrolled in NCI clinical studies. Services are limited to activities conducted in the United States and are organized into three distinct Domains based on accreditation and licensing requirements. Domain 1 encompasses clinical site identification, onboarding, management, training, and provision of biospecimen collection kits, plus identification of existing biospecimen collections. Domain 2 requires comprehensive biorepository services with College of American Pathologists (CAP) Biorepository Accreditation Program (BAP) certification and an onsite board-certified anatomic pathologist. Domain 3 adds Clinical Laboratory Improvement Amendments (CLIA) certification and New York State and California state licensing requirements to support potential return of clinical results to research participants. Contractors must achieve Domain 3 certifications within nine months of contract award to be eligible for Domain 3 Task Order awards.

The contractor must establish Standard Operating Procedures (SOPs) for submission and government approval and meet NCI Best Practices for Biospecimen Resources. Key personnel requirements include a Project Manager (bachelor's degree, 5+ years' program/project management experience), Clinical Site Manager/Clinical Research Associate for Domain 1 (bachelor's in life science, 5+ years' clinical experience preferably in cancer research), Board-Certified Anatomic Pathologist for Domains 2 and 3 (MD, 5+ years' pathology services experience), and Laboratory/Biorepository Director for Domains 2 and 3 (PhD, 5+ years' biorepository operations experience). Common deliverables for all Domains include kick-off meeting materials, project management and communication plans, employee rosters, financial reports by task with labor hours and Level of Effort projections, phase-out plans, incident/deviation reports, IT security documentation, and Section 508 accessibility compliance reports. Additional Domain-specific deliverables include clinical site applications and agreements, kit management and tracking plans, Quality Management Plans, training plans, laboratory SOPs, LIMS data dictionaries, CAP BAP and CLIA certifications, and reporting mechanisms for biospecimen inventory and quality metrics accessible to government personnel via secure dashboards or shared documents.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

STATEMENT OF WORK (SOW)

TITLE: BIOSPECIMEN COLLECTION AND BIOBANKING SERVICES (BCBS)

1.0 SCOPE.

As part of the overall mission to develop novel diagnostics and therapies for cancer, the National Institutes of Health (NIH), National Cancer Institute (NCI), and other Institutes and Centers utilize research biospecimens to include tissues, blood, and other bodily fluids donated by research participants enrolled in clinical studies to conduct and support research. The NIH Office of Acquisitions on behalf of the Division of Cancer Treatment and Diagnosis (DCTD) has a new requirement for biospecimen collection and biorepository services that encompasses collection, processing, storage and distribution of biospecimens. It is critical that researchers use biospecimens and associated data of known quality for studies that investigate the causes, biology, diagnosis, prevention, and treatment of cancer. DCTD’s primary focus is on the development of novel diagnostics and therapies for cancer patients, which depends on the use of quality biospecimens donated by cancer patients who have consented to participate in NCI clinical studies.

Key strategic goals include representing the population of the United States in biospecimen and data collection, and collection of high quality, well annotated cancer biospecimens (tissue and blood) from consented participants.

1.1 NCI needs biospecimens that meet the requirements and qualifications of research studies that may include, but are not limited to, the following types of research studies: development of patient-derived animal models; characterization of tumors using clinical- and research-grade genomic sequencing; proteomic studies; pharmacodynamic studies; development and validation of clinical assays; performance of clinical testing on research biospecimens allowing for return of clinical test results to providers and patients; and collection and management of biospecimen resources for future research.

1.2 The anticipated Biospecimen Collection and Biobanking Services (BCBS) Multiple Award, Indefinite Delivery Indefinite Quantity (MA IDIQ) contract is designed to promote maximum flexibility for NCI and provide a streamlined and efficient process for awarding Task Orders. This procurement will establish a group of highly specialized and highly qualified Contractors that possess the capabilities to compete on specific service requirements outlined in Task Orders.

Future Task Orders may be issued to service other NIH Institutes and Centers.

1.3 For the purposes of this contract, the BCBS support services include biospecimen collection and biorepository support activities conducted in the United States. General requirements are organized into three Domains as described below:

1.3.1 Domain 1: Domain 1 describes the biospecimen collection activities needed to identify and manage medical institutions (herein referred to as Clinical Sites) across the United States to engage and enroll cancer patients onto NCI biospecimen collection studies and to provide biospecimen collection kit services for the studies. NCI biospecimen collection studies will include collection of biospecimens and associated medical data. Some studies will require the identification of existing cancer biospecimen collections that meet quality and quantity metrics prescribed by the NCI and that are appropriately consented for use by NCI. The Contractor(s) shall ensure that these activities are conducted safely, efficiently, and in compliance with regulatory requirements as specified in Institutional Review Board

(IRB)-approved NCI studies.

1.3.2 Domain 2: Domain 2 describes comprehensive biorepository services performed under biorepository accreditation by the College of American Pathologists’ Biorepository Accreditation Program (CAP/BAP) and employing an onsite board-certified anatomic pathologist.

1.3.3 Domain 3: Domain 3 describes comprehensive biorepository services performed under biorepository accreditation by the College of American Pathologists’ Biorepository Accreditation Program (CAP/BAP) and employing an onsite board-certified anatomic pathologist, with additional requirements related to the potential return of results to research participants:

performance under the Clinical Laboratory Improvement Amendment (CLIA) accreditation and additional licensing requirements of New York State and California. The contractor shall possess or shall be in the process of obtaining CLIA accreditation and the license and capabilities to conduct requirements in New York State and CA.

1.4 BACKGROUND. This effort is comprised of new requirements that will consist of the three individual Domains described above that encompass the full spectrum of biospecimen collection from consenting participants to biorepository services.

1.5 OBJECTIVE. To obtain specialized services for a) the identification and coordination of Clinical Sites to manage and oversee NCI studies for biospecimen collections, and b) the receipt, processing, storage, and distribution of biospecimens and associated data for current and future cancer research; in addition, to identify existing high-quality cancer biospecimen collections in institutions such as academic research institutions, hospitals and research foundations for transfer to and use by NCI.

2.0 APPLICABLE DOCUMENTS.

The Contractor shall write, update and follow Standard Operating Procedures (SOPs) in their fulfillment of contract duties related to implementation of NCI biospecimen collection studies at Clinical Sites and the collection, processing, and handling of biospecimens. The Contractor shall submit the SOPs to the Government for approval.

2.1 Government Documents. The Contractor shall use the NCI Best Practices for Biospecimen Resources (March 2016) in developing and conducting their activities. https://dctd.cancer.gov/data-tools-biospecimens/biospecimens-biobanks/resources/best-practices

Items to be delivered required for all Domains

2.1.1 The Contractor will provide an agenda for Kick-Off meeting and participation in Kick-Off meeting and meeting minutes following the meeting.

2.1.2 The Contractor will provide a Project Management Plan with Communication Plan

2.1.3 The Contractor will provide a roster of Contractor’s employees who will work on the contract

2.1.4 The Contractor will provide a Financial Task Order Reports, including accomplishments by task, labor hours expended, monthly expenditures by task/sub-task, and projected Level of Effort (LOE) and projected cost for the following month.

2.1.5 The Contractor will provide a Phase-out Plan

2.1.6 The Contractor will provide a Significant Incident and Deviation Report

• IT Security Plan (IT-SP)

• IT Risk Assessment (IT-RA)

• Federal Information Processing Standard (FIPS) 199 Assessment

• IT Security Certification and Accreditation

• IT Security Awareness Training

• Reporting of new and departing employees

• Contractor – Employee Non-Disclosure Agreements

• HHS Checklist for websites, web applications & Software

• Section 508 Reporting

• Based on the HHS OS Factsheets & Reference Guides (Accessibility Technical Resources |

HHS.gov) and GSA’s Create Accessible Digital Products | Section508.gov, the vendor shall submit verification of digital accessibility through the use of the Accessibility Conformance Checklists | HHS.gov, the vendor shall submit annual reports confirming the Section 508-conformance of all other digitally formatted reports.

• Note that one representative Section 508 Accessibility Conformance Checklist as a report per file type shall suffice – that is, one Microsoft Word checklist shall represent all Word files submitted under this contact, one Microsoft PowerPoint checklist shall represent all PowerPoint files submitted under this contact, one Adobe PDF checklist shall represent all PDF files submitted under this contact, etc. This applies for each reporting period.

3.0 REQUIREMENTS

The Contractor, as an independent contractor and not as an agent of the Government, shall furnish the necessary resources, except those provided as Government Furnished Property (GFP), to perform the work specified in this Statement of Work (SOW). The Contractor shall not perform any requirement not specifically assigned under BCBS Task Orders. Please refer to Section 4.2 for Program Management and Administration Requirements applicable to all Domains.

3.1 DOMAIN 1: CLINICAL SITES IDENTIFICATION AND ONBOARDING, CLINICAL SITE

MANAGEMENT, TRAINING, PROVISION OF KITS, AND IDENTIFICATION OF EXISTING

BIOSPECIMEN COLLECTIONS.

3.1.1 CLINICAL SITE IDENTIFICATION AND ONBOARDING

3.1.1.1 The Contractor shall engage and manage Clinical Sites and Clinical Site networks that are currently engaged in NCI studies, as evidenced by information provided by the NCI COR, to implement NCI-sponsored biospecimen collection studies.

3.1.1.2 The Contractor shall identify, evaluate, and onboard new Clinical Sites that are not already engaged in NCI studies to implement NCI-sponsored biospecimen collection studies.

3.1.1.3 The Contractor shall be the primary point of contact and coordinator for Clinical Sites that engage and enroll cancer patients in NCI-sponsored biospecimen collection studies.

3.1.1.4 The Contractor shall initiate agreements and facilitate study activation with each Clinical Site.

3.1.1.5 The Contractor shall identify and onboard Clinical Sites that align with the goals of the NCI to increase the participation of people who typically don’t participate in research, including rural populations, older adults, pediatric patients, and communities with people who have low socioeconomic status.

3.1.1.6 The Contractor shall identify and onboard Clinical Sites to collect biospecimens using procedures which may include, but are not limited to, surgical resections, biopsy procedures, bone marrow aspirations, blood draws, as well as collection of fecal matter, sputum, and other bodily fluids. Some procedures may be standard of care, and some may be specifically for research purposes.

3.1.1.7 For some studies, as specified in Task Orders, the contractor shall identify and onboard Clinical Sites that have demonstrated experience in community engagement and outreach regarding cancer research. Task Orders will outline any specific requirements to support engagement efforts. The ability to identify and onboard Clinical Sites with experience in community engagement is preferred but not required.

3.1.2 CLINICAL SITE MANAGEMENT

3.1.2.1 The Contractor shall provide regulatory and legal documentation to the Clinical Sites and provide instructions to ensure compliance with regulatory/legal requirements regarding “Human Subjects’ Research”.

3.1.2.2 The Contractor shall manage payments, legal agreements, and other contractual documentation for Clinical Sites.

3.1.2.3 The Contractor shall become an expert in the details of the NCI-provided study protocol(s) to address study-specific questions from Clinical Sites.

3.1.2.4 The Contractor shall notify and collaborate with the NCI if the contractor is unable to respond to complex Clinical Site questions regarding any NCI-provided study protocol to ensure accuracy and appropriateness of its response.

3.1.2.5 The Contractor shall provide coordination and evaluation on continual and regularly occurring intervals of progress for studies to ensure the study and enrollment goals are met.

3.1.2.6 The Contractor shall provide evaluation at regularly recurring intervals to ensure biospecimens and data of sufficient quality are being collected.

3.1.2.7 The Contractor shall travel to Clinical Sites when required to train and direct sites and perform QA/QC. Specific Travel requirements will be identified at the Task Order level.

3.1.2.8 The Contractor shall maintain Material Transfer Agreements (MTA’s) and Data Use Agreements (DUA’s), as required, for the biospecimens and data provided by the Clinical Sites. The terms and conditions of the MTA’s and DUA’s shall be incorporated into the contracts prepared by the contractor with Clinical Sites.

3.1.2.9 When required by specific Task Orders, the Contractor shall provide a compensation method to Clinical Sites for compensating participants for their research participation. The Contractor shall consult with the NCI about reasonable compensation amounts. The ability to provide compensation to participants is preferred but not required.

3.1.2.10 The Contractor shall work with the NCI to determine appropriate reimbursement to Clinical Sites for biospecimen and data collection activities. The Contractor shall reimburse the Clinical Sites based on the reimbursement criteria agreed upon with NCI in a timely manner.

3.1.2.11 The Contractor shall use NCI-provided information management systems to electronically record the enrollment and registration of patients and execute data entry of this information at Clinical Sites.

3.1.2.12 The Contractor shall use NCI-provided information management systems to enable the collection of clinical data at the Clinical Sites. Depending on the specific study requirements, this data may include, but not be limited to, demographics, diagnoses, treatments, medications, procedure type, test results, imaging, pathology reports, histology, stage, ischemic time, family medical history, social and environmental factors, and treatment response.

3.1.3 STUDY AND BIOSPECIMEN COLLECTION TRAINING

3.1.3.1 The Contractor shall collaborate with the NCI to develop, conduct and document attendance of training for study staff at Clinical Sites; records of such shall be available for periodic inspections by the NCI. Training will consist of general human subjects’ research and regulatory training. Additional required trainings may include, but be not limited to, protocol training such as participant eligibility criteria, informed consent procedures, registering a patient for a study, ordering kits, clinical data collection and management, biospecimen collection procedures, onsite processing, packing, biospecimen handling procedures, and shipping. Required trainings will be determined at the Task Order level.

3.1.4 PROVISION OF BIOSPECIMEN COLLECTION KITS

3.1.4.1 When specific NCI studies do not require the services of a comprehensive biorepository, the contractor shall develop, manage, and distribute biospecimen collection kits for tissue, blood, and other biological material.

3.1.4.2 The Contractor shall establish and follow written policies and procedures for a Quality Management Plant that is designed to monitor and evaluate the ongoing and overall quality of the biospecimen kit management processes.

3.1.4.3 The Contractor shall provide kits for freshly collected and archival material that may include, but be not limited to, tissues and/or blood, other biospecimens, freshly frozen tissue, fresh tissue in formalin, Formalin-Fixed and Paraffin-Embedded (FFPE) blocks, bone marrow aspirate, urine, saliva and stool for shipment to NCI laboratories.

3.1.4.4 The Contractor shall employ “cold chain shipping logistics” to support collection workflows and processes for biospecimens requiring cold shipping.

3.1.4.5 The Contractor shall provide appropriate shipping containers, shipping labels, account information and/or prepaid shipping forms, packaging and shipping instructions, and shall track kit shipments to support high-quality biospecimen collection in accordance with the NCI Best Practices for Biospecimen Resources.

3.1.4.6 The contractor will follow Department of Transportation rules for shipping biohazardous material or will provide online instructions for sites to order and track kits.

3.1.5 IDENTIFICATION OF EXISTING BIOSPECIMEN COLLECTIONS

3.1.5.1 The Contractor shall identify and evaluate the suitability, quality, and quantity of existing biospecimen resources, including accompanying data, in the United States, based on the criteria provided by the NCI, that have the potential availability for transfer and use. Specific requirements will be identified at the Task Order level.

3.1.5.2 The contractor shall initiate agreements with the owners of such existing biospecimen and data resources to transfer the biospecimens and data to NCI’s designated biorepository and data repository.

3.1.6 INFORMATION TECHNOLOGY SPECIFIC TO DOMAIN 1

3.1.6.1 Task Order Technical Reports. The Contractor shall provide a readily available, easily accessible mechanism for the Government and its contractors to view a report of biospecimen collection progress and other relevant study metrics at all sites, for all studies, as specified in Task Orders. This may take the form of a secure shared document(s) or a secure, web-based electronic dashboard or other secure method per the contractor’s capabilities and shall not contain any identifying information about research participants. Study information required will be specified at the Task Order level and may include, but not be limited to, the operational status of Clinical Sites, number of patients approached for enrollment for a study, number of patients enrolled, enrolled patient demographics, number and types of kits ordered by each Clinical Site, number and type of biospecimens collected from each participant at each Clinical Site and number of biospecimens received by the NCI designated laboratories.

3.1.7 ITEMS TO BE DELIVERED SPECIFIC TO DOMAIN 1

3.1.7.1 The Contractor shall provide a written application to assess capability and capacity of Clinical Sites to participate in NCI biospecimen collection studies.

3.1.7.2 The Contractor shall provide a plan for kit development, management, ordering and tracking of kits delivered to Clinical Sites.

3.1.7.3 The Contractor shall provide a plan for the mechanism to verify tracking of biospecimen shipments from Clinical Sites, receipt at NCI labs, and biospecimen quality.

3.1.7.4 The Contractor shall provide a Quality Management Plan (QMP) for the biospecimen kit management processes.

3.1.7.5 The Contractor shall provide written instructions for biospecimen collection kits for the Clinical Sites.

3.1.7.6 Standard Operating Procedures (SOP) for use by the Clinical Sites, for activities related to biospecimen collection studies, in the form of a Laboratory Manual.

3.1.7.7 The Contractor shall provide a plan for training of Clinical Site staff in all SOPs and activities related to biospecimen collection studies.

3.1.7.8 The Contractor shall provide a plan for the mechanism to provide reimbursement to Clinical Sites.

3.1.7.9 The Contractor shall provide a copy of the finalized and signed written agreement with each Clinical Site.

3.1.7.10 The Contractor shall provide regulatory and legal documents to the Clinical Sites to ensure compliance with regulatory/legal requirements regarding “Human Subjects’ Research.”

3.1.7.11 The Contractor shall provide a plan for a secure mechanism to view a report of biospecimens collected, received, processed, stored, by the NCI and its contractors.

3.1.7.12 The Contractor shall provide a plan of a secure mechanism to view a report of Clinical Sites onboarded, the enrolled participants at each Clinical Site and their demographics and cancer types.

3.1.7.13 The Contractor shall provide a mechanism to provide reimbursement to Clinical Sites.

3.2 DOMAIN 2: COMPREHENSIVE BIOREPOSITORY SERVICES, ACCREDITATION BY

THE COLLEGE OF AMERICAN PATHOLOGISTS (CAP)/BIOREPOSITORY

ACCREDITATION PROGRAM (BAP), PATHOLOGY AND HISTOLOGY, TRAINING,

QUALITY ASSURANCE AND INFORMATION TECHNOLOGY.

3.2.1 COMPREHENSIVE BIOREPOSITORY SERVICES

3.2.1.1 The Contractor must manage the receipt, processing, storage and distribution of a variety of biospecimen types obtained from patients enrolled in NCI biospecimen collection studies.

3.2.1.2 The Contractor shall provide biospecimen receipt and accessioning from Clinical Sites. The Contractor shall log all incoming shipments, determine if packages and biospecimens are compromised, communicate any issues to the shipping party and the Government, and record this information in their information management system.

3.2.1.3 The Contractor shall support, whenever possible, Saturday biospecimen receipt and processing for tissue and blood for patients who have procedures (surgeries, biopsy procedures, blood draws, etc.) on Fridays.

3.2.1.4 The Contractor shall provide custom and appropriate biospecimen collection, packaging and temperature appropriate shipping supplies for studies that require the biospecimens to be shipped directly to the biorepository from the Clinical Sites, as specified in Task Orders and per study requirements. The Contractor shall provide biospecimen collection kits for freshly collected or archival material, i.e., tissues, and/or blood, and/or other biospecimens, including but not limited to freshly frozen tissue, fresh tissue in formalin, blood, Formalin-Fixed and Paraffin-Embedded (FFPE) blocks, bone marrow aspirate, urine, saliva and stool for shipment to the biorepository.

3.2.1.5 The Contractor shall employ cold chain shipping logistics to support all collection workflows and processes, including the appropriate shipping containers, shipping labels, account information, and packaging and shipping instructions to support high-quality biospecimen collection for those biospecimen types that require cold shipping.

3.2.1.6 Each biospecimen and derivative shall be assessed for quality and quantity as part of quality control procedures, as specified in Task Orders and per study requirements.

3.2.1.7 The Contractor shall have the capabilities to process biospecimens, including but not limited to blood biospecimens, tissues received frozen, tissues received as formalin fixed paraffin embedded (FFPE), and tissues received in formalin or other preservatives, serial slicing, cryopulverization, and laser capture microdissection. The contractor shall process and aliquot biospecimens as specified in Task Orders and to include, but not limited to, blood and tissue processing to analytes including nucleic acids and proteins.

3.2.1.8 The Contractor shall stay up to date on scientific and market advancements related to biospecimen collection, processing, and storage. Based on this information, the contractor shall make recommendations to the NCI on studies and procedures as applicable.

3.3.1.9 The Contractor shall conduct method development and validation studies, as required, that are related to testing and changing biospecimen collection, processing, and storage methodology relevant to NCI studies.

3.2.1.10 The Contractor shall store biospecimens and derivatives in accordance with CAP/BAP requirements and SOP’s as specified in Task Orders and per study requirements. The contractor shall monitor storage equipment continuously and maintain alarm systems for temperature, access, and power.

The contractor shall monitor primary biospecimen and derivative (e.g., plasma, DNA, and RNA) stock levels for each NCI study and monitor the stability of the analytes per study requirements.

3.2.1.11 The Contractor shall provide continued management, tracking, and distribution of the biospecimens after collection from participants and after a study has ceased, as specified in Task Orders and per study requirements. This is termed “Legacy Phase.”

3.2.1.12 The Contractor shall provide services for the transfer of collections of biospecimens and associated data in and out of the biorepository, as specified in Task Orders. This may include accepting legacy collections for storage and distribution.

3.2.1.13 The Contractor shall provide periodic quality evaluation of selected samples, as specified in Task Orders and per study requirements.

3.2.1.14 The Contractor shall retrieve biospecimens from storage for processing and distribution to approved researchers, as specified in Task Orders and per study requirements.

3.2.2 ACCREDITATION REQUIREMENTS

3.2.2.1 The Contractor shall be accredited by the College of American Pathologists (CAP) Biorepository Accreditation Program and maintain accreditation during the life of the contract.

3.2.3 PATHOLOGY AND HISTOLOGY SERVICES

3.2.3.1 The Contractor shall have on staff, onsite at the biorepository, a board-certified anatomic pathologist to perform and/or supervise the requirements for pathology services as detailed in the tasks below.

3.2.3.2 The Contractor shall have capabilities for histological processing of tissues whether received and stored as frozen, in formalin or other preservative, or formalin-fixed paraffin embedded (FFPE) or other embedded tissues.

3.2.3.3 The pathologist shall examine the solid tumor biospecimens and hematologic malignancy biospecimens received, review pathology reports from the Clinical Sites, and report concurrence or divergence of histological annotation to the research program, and in the case of divergence, report findings to the NCI study team and to the pathologist at the contributing Clinical Site.

3.2.3.4 The pathologist and/or their trained and designated histology technician shall enrich tissue biospecimens for tumor nuclei sufficient for tumor molecular characterization assays or other analysis, as required.

3.2.3.5 The Contractor shall electronically record the findings from pathology review, scan Hematoxylin and Eosin (H&E) slides using appropriate imaging software, store and share pathology review data and images, and support the transfer of images and annotation data to another database or an external storage device as required.

3.2.4 TRAINING

3.2.4.1 The contractor shall collaborate with the NCI to develop, conduct and document attendance of training for study staff at Clinical Sites, which shall be available for periodic inspections by the NCI.

Training will consist of biospecimen collection procedures, onsite processing, packing, biospecimen handling procedures, and shipping. Required trainings will be determined at the Task Order level.

3.2.5 QUALITY MANAGEMENT PLAN

3.2.5.1 The Contractor shall have written, as part of their accreditation under CAP BAP, a comprehensive Quality Management Plan (QMP) that is designed to monitor and evaluate the ongoing and overall quality of all biobanking activities. The Contractor shall follow, maintain and update their QMP as required, and it shall be delivered by the Contractor to the COR for approval.

3.2.5.2 The QMP shall include all elements required by the CAP BAP, including but not limited to how staff with the appropriate qualifications and competencies will be trained and tested on the procedures and policies that shall be followed, and how metrics will be tracked appropriately.

3.2.5.3 The QMP shall also include policies regarding how equipment will be maintained, calibrated and validated, and written SOPs will be developed, approved and followed.

3.2.5.4 The QMP shall also include the quality assurance processes, to include quality planning, quality control activities, and quality assurance audits and reviews, as relevant to the requirements by CAP/BAP, staff training and testing on procedures and policies that shall be followed, and the tracking processes of metrics in accordance with individual Task Orders.

3.2.5.5 The Contractor shall implement and maintain procedures that document, measure, and ensure quality assurance, meet needs and provide customer satisfaction. The Contractor shall make this information available to the Government upon request.

3.2.6 INFORMATION TECHNOLOGY SUPPORT SPECIFIC TO DOMAIN 2

3.2.6.1 The Contractor shall have an existing data management solution such as a Laboratory Information Management System and follow best practices for tracking of pre-analytical factors and detailed inventory management for all biorepository activities, as per CAP BAP requirements.

3.2.6.2 The software tracking system shall include the following requirements:

• Adherence to data security standards which include Health Insurance Portability and Accountability Act (HIPAA) regulations, FDA guidelines on electronic records and electronic signatures (21 CFR 11), and Federal Information Security Management Act (FISMA) – at minimum ‘Low”.

• Compliance with requirements for Section 508 standards for Information and Communication Technology (see Section 508 Requirements section).

• Capabilities to support and log all biospecimen receipts, locations, removals, movements, processes and modifications, problem flags, and distributions.

• Capabilities to add data elements as requested by the NCI.

• Capabilities to support Application Programming Interfaces (APIs) to transfer biospecimen associated data to other systems including clinical data management systems, designated data center(s), and/or NCI online biospecimen catalogs, as identified by NCI.

• Capabilities to track all biospecimen chain of custody variables including location, time and temperature stamps, and biospecimen parent/child relationships.

• Capabilities to store data on appropriate biospecimen pre-analytical factors.

• Capabilities to create and/or receive and track multiple externally generated Unique IDs for participants and biospecimens that adhere to the NCI Best Practices for Biospecimen Resources and protect participant identity.

• Capabilities to support ID generation and its association with externally generated IDs.

• Capabilities to provide auditing and reporting.

3.2.6.3 Technical Reports of the Task Order of biospecimen inventory status. The Contractor shall provide a readily available, easily accessible mechanism for the Government and its contractors to view a report of biospecimens collected, received, processed and stored, along with quality metrics, as specified in Task Orders. This may take the form of a static, secure shared document(s), or a secure, real-time, web-based electronic dashboard, or other secure method per the contractor’s capabilities. Such reports and/or dashboards shall not contain any identifying information about research participants. Electronic reports and/or dashboards shall be 508 compliant. Study information required will be specified at the Task Order level and may include, but not be limited to, number and types of kits ordered by each Clinical Site, number and type of biospecimens collected from each participant at each Clinical Site, number and type of biospecimens received, processed and stored at the Contractor’s site.

3.2.7 ITEMS TO BE DELIVERED SPECIFIC FOR DOMAIN 2

3.2.7.1 The Contractor shall provide their CAP BAP Accreditation documents.

3.2.7.2 The Contractor shall deliver the LIMS data dictionary, containing all relevant data elements, their definitions and their format and acceptable ranges.

3.2.7.3 The Contractor shall deliver evidence and summary of software functionality of a fully operational inventory software system, such as a LIMS.

3.2.7.4 The Contractor shall develop and deliver a written plan for biospecimen collection kits for each biospecimen collection study.

3.2.7.5 The Contractor shall develop and deliver a written plan for tracking of kits and biospecimen shipments to Clinical Sites and from Clinical Sites to NCI laboratories and the biorepository.

3.2.7.6 The Contractor shall develop and deliver for approval all laboratory SOPs to be used for NCI studies.

3.2.7.7 The Contractor shall provide an approved IRB protocol for their biorepository operations or waiver, as applicable.

3.2.7.8 The Contractor shall provide a mechanism for NCI to view a report of biospecimens collected, received, processed and stored, along with their quality metrics.

3.2.7.9 The Contractor shall provide a plan for hosting and remote viewing of histology images.

3.2.7.10 The Contractor shall provide a capability plan for biospecimen processing into Molecular Analytes and reporting of QC metrics.

3.2.7.11 The Contractor shall provide a plan for the reporting of discordant histology findings to the Clinical site if found by Contractor pathologist.

3.2.7.12 The Contractor shall provide a plan for the return of biospecimens from the biorepository to the Clinical Site if required due to a request by the Clinical Site.

3.3 DOMAIN 3: COMPREHENSIVE BIOREPOSITORY SERVICES, ACCREDITATION BY

THE COLLEGE OF AMERICAN PATHOLOGISTS (CAP)/BIOREPOSITORY

ACCREDITATION PROGRAM (BAP), CLINICAL LABORATORY IMPROVEMENT

AMENDMENTS OF 1988 (CLIA) AND PATHOLOGY SUPPORT

3.3.1 COMPREHENSIVE BIOREPOSITORY SERVICES

3.3.1.1 The Contractor shall provide comprehensive biorepository services as described in Domain 2 Sections 3.2.1 through 3.2.6.3 above. Additional requirements for Domain 3 are itemized below.

3.3.2 ACCREDITATION REQUIREMENTS (CLIA)

3.3.2.1 The comprehensive biorepository activities and biospecimen receipt, handling and processing in Domain 3 must be conducted in facilities that are certified as specified by the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations.

3.3.2.2 The Contractor shall have achieved CLIA accreditation for its biorepository activities. If CLIA has not been achieved or is in process, the contractor shall achieve CLIA within 9 months of contract award and shall provide evidence with its submitted proposal for award of the base contract of the status of CLIA and the anticipated time frame as to when it will be achieved. Note that if CLIA is in process, the contractor shall not be eligible for award of any Task Order competed under Domain 3 until CLIA certification has been achieved.

3.3.2.3 State Licensing for Biospecimen Receipt and handling. The Contractor shall have authorization by the New York State (NYS) Department of Health to receive and handle specimens collected from NYS research participants that are destined for clinical testing. If NYS licensing has not been achieved or is in process, the contractor shall achieve NYS licensing within 9 months of contract award and shall provide evidence with its submitted proposal for award of the base contract of the status of the license and the anticipated time frame as to when it will be achieved. Please note that if NYS licensing is in process, the contractor shall not be eligible for award of any Task Order competed under Domain 3 until NYS licensing has been achieved.

3.3.2.4 The Contractor shall hold a license as required by the State of California (CA) to support clinical testing for CA research participants. If CA State licensing has not been achieved or is in process, the contractor shall achieve CA State licensing within 9 months of contract award and shall provide evidence with its submitted proposal for award of the base contract of the status of the license and the anticipated time frame as to when it will be achieved. note that if CA State licensing is in process, the contractor shall not be eligible for award of any Task Order Competed under Domain 3 until CA State licensing has been achieved.

3.3.4 ITEMS TO BE DELIVERED SPECIFIC TO DOMAIN 3

The contractor shall deliver all of the items specific for Domain 2, as well as the items below:

3.3.4.1 The Contractor shall deliver the CLIA certificate. If the certificate is not in place at time of contract award, the Contractor shall deliver, within 2 weeks of contract award, a plan for achieving CLIA accreditation within 9 months of contract award.

3.3.4.2 The Contractor shall deliver the SOPs related to biospecimen handling for CLIA testing.

3.3.4.3 The Contractor shall deliver evidence of their New York State (NYS) Department of Health License to receive and handle specimens collected from NYS research participants that are destined for clinical testing. If the license is not in place at time of contract award, the Contractor shall deliver, within 2 weeks of contract award, a plan for obtaining the license within 9 months of contract award.

3.3.4.4 The Contractor shall deliver evidence of their license as required by the State of California (CA) to support clinical testing for CA research participants. If CA State licensing has not been obtained at the time of contract award, the Contractor shall deliver, within 2 weeks of contract award, a plan for obtaining the license within 9 months of contract award.

4.0. GENERAL CONTRACT REQUIREMENTS FOR BASE CONTRACT DOMAIN 1, 2,

AND 3.

4.1 Key Personnel

4.1.1 At the base IDIQ level, the contractor shall provide a Program Manager (PM) or a designated representative, who shall be available during normal duty hours of 8:00AM – 5:00PM Eastern Time (ET) to perform overall management of the base contract. The PM shall be the contractor’s primary point of contact and shall have the authority to act or make decisions on all matters on behalf of the contractor. The contractor shall designate an alternate who shall be authorized to make decisions in the absence of the PM. The contractor shall determine the staffing of key personnel or other supervisory, management, and administrative personnel as they deem necessary to successfully manage the proposed workforce.

KEY PERSONNEL QUALIFICATIONS

DOMAIN POSITION EDUCATION EXPERIENCE

Domain 1,2,3

Project Manager A bachelor's degree in business, management, or a life science

At least 5 years’ experience in program or project management.

Strong leadership and communication skills, highly organized, experience with budgeting and resource allocation.

Domain 1 Clinical Site Manager/Clinic al Research Associate

A bachelor’s degree in a life science, master’s degree preferred

At least 5 years’ experience of relevant clinical experience, preferably in cancer research.

Experience with training and guiding site staff in study conduct, protocol and data collection, and monitoring sites to ensure compliance with regulatory requirements.

Domains 2,3

Board Certified Anatomic Pathologist

MD At least 5 years’ experience performing pathology services on human tissue biospecimens

Domains 2,3

Laboratory/Bior epository Director

PhD At least 5 years’ experience in biorepository operations and management

4.1.2 The Contractor may not replace key personnel without prior notice to the COR and the CO.

Replacements shall have comparable qualifications. No substitutions in key personnel shall be made except in accordance with this paragraph. All proposed substitutions must be submitted in writing 30 days (180 days if specialized certification is to be obtained) in advance of the proposed substitutions to the CO. The COR will review the resume to ensure Contract Requirements are met. Should the Contractor fail to provide a suitable substitution as determined by the CO, this will be considered non-performance. Ten calendar days prior to the start of performance, the Contractor shall submit to the Government, in writing, the names, work addresses, and the telephone numbers of the key personnel to perform work under this SOW.

4.2 PROGRAM MANAGEMENT AND ADMINISTRATION REQUIREMENTS

4.2.1 The contractor shall implement and maintain a responsive, efficient and effective management structure that can interface with Government personnel.

4.2.2 The contractor shall ensure adequate and efficient staffing levels during the period of performance.

4.2.3 The contractor shall implement, maintain, coordinate, and integrate all activities needed to execute the requirements as detailed in this Statement of Work

4.2.4 The contractor shall coordinate and integrate issued Task Order activities including staffing decisions, prioritizing support for individual Task Orders, managing/monitoring sub-contracts and consultants, which may include one or more of the Domains defined above.

4.2.5 The contractor shall develop a Project Management Plan including a Communication Plan for each issued Task Order. Specific details of the requirements for each project management plan will be provided at the Task Order level.

4.2.6 The contractor shall host a Kick-Off meeting to be conducted virtually within 30 days of contract award. The contractor shall provide an agenda prior to the meeting, and deliver meeting minutes and presentation material within a week after the meeting,

4.2.7 The contractor shall host or attend Government reviews addressing cost, schedule, and performance on individual Task Orders.

4.2.8 The contractor shall submit meeting agendas, minutes, presentation materials for meetings and reviews as specified in individual Task Orders.

4.3 CONTRACT ADMINISTRATION

4.3.1 The contractor shall provide timely identification of issues related to the contract or contract personnel, corrective action plans for contract-related deficiencies, and Task Order contract proposal submittals. During the performance of any Task Order, the contractor shall include any problems identified and corrective action in the monthly and quarterly financial and/or technical reports, as defined at the Task Order level. The contractor is expected to establish a history of reasonable and cooperative behavior and effectively manage subcontracts. The contractor shall seek to ensure professional and ethical behavior of all Contractor and subcontractor personnel.

4.3.2 The contractor shall possess a flexible organization to provide a rapid-response capability to meet last-minute adjustments to requirements. Personnel must be versatile and must be able to adapt to situations where the contractor needs to respond to or contact the study Principal Investigator and/or the study team within a few hours to address eligibility questions, procedural questions, data questions, or shipment questions.

4.3.3 The contractor shall be responsible for any subcontract management necessary to integrate work performed on these requirements and shall be responsible and accountable for subcontractor performance on these requirements. Contractors may add subcontractors to their team after notification to the COR for situational awareness.

4.3.4 The Contractor shall accomplish the assigned work by employing and using qualified personnel with appropriate combinations of education, training, qualifications, certifications and experience. The Contractor shall ensure the labor categories, labor rates, and labor hours are utilized efficiently in the performance of each Task Order. The Contractor shall provide the necessary resources and infrastructure to manage, perform, and administer the contract.

4.3.5 The Contractor shall provide for receipt and coordination of task assignments, rapid resolution of questions and other issues associated with this contract, continuity in the knowledge and application of all applicable regulations.

4.4 508 COMPLIANCE

Section 508 of the Rehabilitation Act, as amended by the Workforce Investment Act of 1998 (P.L. 105-220) requires that when Federal agencies develop, procure, maintain, or use information and communication technology (ICT), it shall be accessible to people with disabilities. Federal employees and members of the public who have disabilities must have access to, and use of, information and data that is comparable to people without disabilities.

E201 Application

E201.1 Scope. ICT that is procured, developed, maintained, or used by agencies shall conform to the Revised 508 Standards.

E205 Electronic Content

E205.1 General. Electronic content shall comply with E205.

E205.2 Public Facing. Electronic content that is public facing shall conform to the accessibility requirements specified in E205.4.

E205.3 Agency Official Communication. Electronic content that is not public facing shall conform to the accessibility requirements specified in E205.4 when such content constitutes official business and is communicated by an agency through one or more of the following:

• A. An emergency notification;

• B. An initial or final decision adjudicating an administrative claim or proceeding;

• C. An internal or external program or policy announcement;

• D. A notice of benefits, program eligibility, employment opportunity, or personnel action;

• E. A formal acknowledgement of receipt;

• F. A survey questionnaire;

• G. A template or form;

• H. Educational or training materials; or

• I. Intranet content designed as a Web page.

E205.4 Accessibility Standard (WCAG 2.0). Electronic content shall conform to Level A and Level AA Success Criteria and Conformance Requirements in WCAG 2.0 (Incorporated by reference, see 702.10.1).

E205.4.1 Word Substitution when Applying WCAG to Non-Web Documents. For non-Web documents, wherever the term "Web page" or "page" appears in WCAG 2.0 Level A and AA Success Criteria and Conformance Requirements, the term "document" shall be substituted for the terms "Web page" and "page". In addition, in Success Criterion in 1.4.2, the phrase "in a document" shall be substituted for the phrase "on a Web page"

E302 Functional Performance Criteria

302.1 Without Vision. Where a visual mode of operation is provided, ICT shall provide at least one mode of operation that does not require user vision.

302.2 With Limited Vision. Where a visual mode of operation is provided, ICT shall provide at least one mode of operation that enables users to make use of limited vision.

302.3 Without Perception of Color. Where a visual mode of operation is provided, ICT shall provide at least one visual mode of operation that does not require user perception of color.

302.4 Without Hearing. Where an audible mode of operation is provided, ICT shall provide at least one mode of operation that does not require user hearing.

302.5 With Limited Hearing. Where an audible mode of operation is provided, ICT shall provide at least one mode of operation that enables users to make use of limited hearing.

302.6 Without Speech. Where speech is used for input, control, or operation, ICT shall provide at least one mode of operation that does not require user speech.

302.7 With Limited Manipulation. Where a manual mode of operation is provided, ICT shall provide at least one mode of operation that does not require fine motor control or simultaneous manual operations.

302.8 With Limited Reach and Strength. Where a manual mode of operation is provided, ICT shall provide at least one mode of operation that is operable with limited reach and limited strength.

302.9 With Limited Language, Cognitive, and Learning Abilities. ICT shall provide features making its use by individuals with limited cognitive, language, and learning abilities simpler and easier.

All Information and Communication Technology (ICT) products and services, including but not limited to electronic reports listed in the Deliverables section of this SOW (i.e., Electronic Documents), submitted shall be conformant with Section 508 of the Rehabilitation Act of 1973.

Additional information about testing documents for Section 508 conformance, including guidance and specific checklists, by application can be found at the US Access Board (Revised 508 Standards and 255 Guidelines access-board.gov), US General Services Administration (Section508.gov), and US Health & Human Services (HHS Accessibility & Section 508).

In addition, we refer the Contractor to the following GSA Section 508 page for guidance on developing electronic documents for accessibility and Section 508-conformance: GSA Section508.gov. Create Accessible Digital Products (https://www.section508.gov/create/). The Contractor may use the respective GSA Section508 checklist (in Microsoft Word format) as a Section 508 report for each document it submits per file type (e.g., Microsoft Word, Microsoft Excel, PDF, etc.) in lieu of HHS’s Checklists in Microsoft Office Excel.

Note that one representative Section 508 Conformance Report per file type per deliverable shall suffice – that is, one Microsoft Word checklist shall represent all Word files submitted, one Microsoft PowerPoint checklist shall represent all PowerPoint files submitted, one Adobe PDF checklist shall represent all PDF files submitted, etc. per deliverable.

File details come from the government source that posted it. Updated .